<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36265587</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>05</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1083-351X</ISSN><JournalIssue CitedMedium="Internet"><Volume>298</Volume><Issue>12</Issue><PubDate><Year>2022</Year><Month>Dec</Month></PubDate></JournalIssue><Title>The Journal of biological chemistry</Title><ISOAbbreviation>J Biol Chem</ISOAbbreviation></Journal><ArticleTitle>Metal migration and subunit swapping in ALS-linked SOD1: Zn<sup>2+</sup> transfer between mutant and wild-type occurs faster than the rate of heterodimerization.</ArticleTitle><Pagination><StartPage>102610</StartPage><MedlinePgn>102610</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">102610</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbc.2022.102610</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0021-9258(22)01053-5</ELocationID><Abstract><AbstractText>The heterodimerization of WT Cu, Zn superoxide dismutase-1 (SOD1), and mutant SOD1 might be a critical step in the pathogenesis of SOD1-linked amyotrophic lateral sclerosis (ALS). Rates and free energies of heterodimerization (&#x394;G<sub>Het</sub>) between WT and ALS-mutant SOD1 in mismatched metalation states-where one subunit is metalated and the other is not-have been difficult to obtain. Consequently, the hypothesis that under-metalated SOD1 might trigger misfolding of metalated SOD1 by "stealing" metal ions remains untested. This study used capillary zone electrophoresis and mass spectrometry to track heterodimerization and metal transfer between WT SOD1, ALS-variant SOD1 (E100K, E100G, D90A), and triply deamidated SOD1 (modeled with N26D/N131D/N139D substitutions). We determined that rates of subunit exchange between apo dimers and metalated dimers-expressed as time to reach 30% heterodimer-ranged from t<sub>30%</sub>&#xa0;= 67.75&#xa0;&#xb1; 9.08 to 338.53&#xa0;&#xb1; 26.95&#xa0;min; free energies of heterodimerization ranged from &#x394;G<sub>Het</sub>&#xa0;= -1.21&#xa0;&#xb1; 0.31 to -3.06&#xa0;&#xb1; 0.12&#xa0;kJ/mol. Rates and &#x394;G<sub>Het</sub> values of partially metalated heterodimers were more similar to those of fully metalated heterodimers than apo heterodimers, and largely independent of which subunit (mutant or WT) was metal-replete or metal-free. Mass spectrometry and capillary electrophoresis demonstrated that mutant or WT 4Zn-SOD1 could transfer up to two equivalents of Zn<sup>2+</sup> to mutant or WT apo-SOD1 (at rates faster than the rate of heterodimerization). This result suggests that zinc-replete SOD1 can function as a chaperone to deliver Zn<sup>2+</sup> to apo-SOD1, and that WT apo-SOD1 might increase the toxicity of mutant SOD1 by stealing its Zn<sup>2+</sup>.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dashnaw</LastName><ForeName>Chad M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department of Chemistry and Biochemistry, Baylor University, Waco, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Ao Yun</ForeName><Initials>AY</Initials><AffiliationInfo><Affiliation>Department of Chemistry and Biochemistry, Baylor University, Waco, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonzalez</LastName><ForeName>Mayte</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Chemistry and Biochemistry, Baylor University, Waco, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koone</LastName><ForeName>Jordan C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Chemistry and Biochemistry, Baylor University, Waco, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaw</LastName><ForeName>Bryan F</ForeName><Initials>BF</Initials><AffiliationInfo><Affiliation>Department of Chemistry and Biochemistry, Baylor University, Waco, Texas, USA. Electronic address: bryan_shaw@baylor.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biol Chem</MedlineTA><NlmUniqueID>2985121R</NlmUniqueID><ISSNLinking>0021-9258</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008670">Metals</NameOfSubstance></Chemical><Chemical><RegistryNumber>J41CSQ7QDS</RegistryNumber><NameOfSubstance UI="D015032">Zinc</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C531617">Amyotrophic lateral sclerosis 1</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008670" MajorTopicYN="N">Metals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015032" MajorTopicYN="N">Zinc</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">asparagine deamidation</Keyword><Keyword MajorTopicYN="N">copper</Keyword><Keyword MajorTopicYN="N">heterodimerization</Keyword><Keyword MajorTopicYN="N">homeostasis</Keyword><Keyword MajorTopicYN="N">motor neuron disease</Keyword><Keyword MajorTopicYN="N">zinc</Keyword></KeywordList><CoiStatement>Conflict of interest The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>20</Day><Hour>19</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36265587</ArticleId><ArticleId IdType="pmc">PMC9667317</ArticleId><ArticleId IdType="doi">10.1016/j.jbc.2022.102610</ArticleId><ArticleId IdType="pii">S0021-9258(22)01053-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wang L.Q., Ma Y., Yuan H.Y., Zhao K., Zhang M.Y., Wang Q., et al. Cryo-EM structure of an amyloid fibril formed by full-length human SOD1 reveals its conformational conversion. Nat. Commun. 2022;13:3491.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9205981</ArticleId><ArticleId IdType="pubmed">35715417</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y., Acerson M.J., Abdolvahabi A., Mowery R.A., Shaw B.F. Gibbs energy of superoxide dismutase heterodimerization accounts for variable survival in amyotrophic lateral sclerosis. J.&#xa0;Am. Chem. Soc. 2016;138:5351&#x2013;5362.</Citation><ArticleIdList><ArticleId IdType="pubmed">27054659</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen P.M., Forsgren L., Binzer M., Nilsson P., Ala-Hurula V., Keranen M.L., et al. Autosomal recessive adult-onset amyotrophic lateral sclerosis associated with homozygosity for Asp90Ala CuZn-superoxide dismutase mutation. A clinical and genealogical study of 36 patients. Brain. 1996;119:1153&#x2013;1172.</Citation><ArticleIdList><ArticleId IdType="pubmed">8813280</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S., Sayana P., Zhang X., Le W. Genetics of amyotrophic lateral sclerosis: an update. Mol. Neurodegener. 2013;8:1&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3766231</ArticleId><ArticleId IdType="pubmed">23941283</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasinelli P., Brown R.H. Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat. Rev. Neurosci. 2006;7:710&#x2013;723.</Citation><ArticleIdList><ArticleId IdType="pubmed">16924260</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M., Durazo A., Whitelegge J.P., Borchelt D.R. An examination of wild-type SOD1 in modulating the toxicity and aggregation of ALS-associated mutant SOD1. Hum. Mol. Genet. 2010;19:4774&#x2013;4789.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2989888</ArticleId><ArticleId IdType="pubmed">20871097</ArticleId></ArticleIdList></Reference><Reference><Citation>Witan H., Kern A., Koziollek-Drechsler I., Wade R., Behl C., Clement A.M. Heterodimer formation of wild-type and amyotrophic lateral sclerosis-causing mutant Cu/Zn-superoxide dismutase induces toxicity independent of protein aggregation. Hum. Mol. Genet. 2008;17:1373&#x2013;1385.</Citation><ArticleIdList><ArticleId IdType="pubmed">18211954</ArticleId></ArticleIdList></Reference><Reference><Citation>Borchelt D.R., Guarnieri M., Wong P.C., Lee M.K., Slunt H.S., Xu Z.S., et al. Superoxide dismutase 1 subunits with mutations linked to familial amyotrophic lateral sclerosis do not affect wild-type subunit function. J.&#xa0;Biol. Chem. 1995;270:3234&#x2013;3238.</Citation><ArticleIdList><ArticleId IdType="pubmed">7852409</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruijn L.I., Houseweart M.K., Kato S., Anderson K.L., Anderson S.D., Ohama E., et al. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science. 1998;281:1851&#x2013;1854.</Citation><ArticleIdList><ArticleId IdType="pubmed">9743498</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J., Lee H., Lee J.H., Kwon D.Y., Genovesio A., Fenistein D., et al. Dimerization, oligomerization, and aggregation of human amyotrophic lateral sclerosis copper/zinc-superoxide dismutase 1 protein mutant forms in live cells. J.&#xa0;Biol. Chem. 2014;289:15094&#x2013;15103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4031559</ArticleId><ArticleId IdType="pubmed">24692554</ArticleId></ArticleIdList></Reference><Reference><Citation>Witan H., Gorlovoy P., Kaya A.M., Koziollek-Drechsler I., Neumann H., Behl C., et al. Wild-type Cu/Zn superoxide dismutase (SOD1) does not facilitate, but impedes the formation of protein aggregates of amyotrophic lateral sclerosis causing mutant SOD1. Neurobiol. Dis. 2009;36:331&#x2013;342.</Citation><ArticleIdList><ArticleId IdType="pubmed">19660548</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu G., Ayers J.I., Roberts B.L., Brown H., Fromholt S., Green C., et al. Direct and indirect mechanisms for wild-type SOD1 to enhance the toxicity of mutant SOD1 in bigenic transgenic mice. Hum. Mol. Genet. 2014;24:1019&#x2013;1035.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4375410</ArticleId><ArticleId IdType="pubmed">25305079</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Deng H.X., Grisotti G., Zhai H., Siddique T., Roos R.P. Wild-type SOD1 overexpression accelerates disease onset of a G85R SOD1 mouse. Hum. Mol. Genet. 2009;18:1642&#x2013;1651.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2667291</ArticleId><ArticleId IdType="pubmed">19233858</ArticleId></ArticleIdList></Reference><Reference><Citation>Audet J.N., Gowing G., Julien J.P. Wild-type human SOD1 overexpression does not accelerate motor neuron disease in mice expressing murine Sod1(G86R) Neurobiol. Dis. 2010;40:245&#x2013;250.</Citation><ArticleIdList><ArticleId IdType="pubmed">20573565</ArticleId></ArticleIdList></Reference><Reference><Citation>Brasil A.A., de Carvalho M.D.C., Gerhardt E., Queiroz D.D., Pereira M.D., Outeiro T.F., et al. Characterization of the activity, aggregation, and toxicity of heterodimers of WT and ALS-associated mutant Sod1. Proc. Natl. Acad. Sci. U. S. A. 2019;116:25991&#x2013;26000.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6926019</ArticleId><ArticleId IdType="pubmed">31796595</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng H.X., Shi Y., Furukawa Y., Zhai H., Fu R., Liu E., et al. Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria. Proc. Natl. Acad. Sci. U. S. A. 2006;103:7142&#x2013;7147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1447523</ArticleId><ArticleId IdType="pubmed">16636275</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science. 1994;264:1772&#x2013;1775.</Citation><ArticleIdList><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukada K., Nagano S., Satoh M., Tohyama C., Nakanishi T., Shimizu A., et al. Stabilization of mutant Cu/Zn superoxide dismutase (SOD1) protein by coexpressed wild SOD1 protein accelerates the disease progression in familial amyotrophic lateral sclerosis mice. Eur. J. Neurosci. 2001;14:2032&#x2013;2036.</Citation><ArticleIdList><ArticleId IdType="pubmed">11860498</ArticleId></ArticleIdList></Reference><Reference><Citation>Graffmo K.S., Forsberg K., Bergh J., Birve A., Zetterstrom P., Andersen P.M., et al. Expression of wild-type human superoxide dismutase-1 in mice causes amyotrophic lateral sclerosis. Hum. Mol. Genet. 2013;22:51&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">23026746</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyd S.D., Ullrich M.S., Calvo J.S., Behnia F., Meloni G., Winkler D.D. Mutations in superoxide dismutase 1 (Sod1) linked to familial amyotrophic lateral sclerosis can disrupt high-affinity zinc-binding promoted by the copper chaperone for Sod1 (Ccs) Molecules. 2020;25:1086.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7179120</ArticleId><ArticleId IdType="pubmed">32121118</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyd S.D., Calvo J.S., Liu L., Ullrich M.S., Skopp A., Meloni G., et al. The yeast copper chaperone for copper-zinc superoxide dismutase (CCS1) is a multifunctional chaperone promoting all levels of SOD1 maturation. J.&#xa0;Biol. Chem. 2019;294:1956&#x2013;1966.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6369272</ArticleId><ArticleId IdType="pubmed">30530491</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayward L.J., Rodriguez J.A., Kim J.W., Tiwari A., Goto J.J., Cabelli D.E., et al. Decreased metallation and activity in subsets of mutant superoxide dismutases associated with familial amyotrophic lateral sclerosis. J.&#xa0;Biol. Chem. 2002;277:15923&#x2013;15931.</Citation><ArticleIdList><ArticleId IdType="pubmed">11854284</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokuda E., Nomura T., Ohara S., Watanabe S., Yamanaka K., Morisaki Y., et al. A&#xa0;copper-deficient form of mutant Cu/Zn-superoxide dismutase as an early pathological species in amyotrophic lateral sclerosis. Biochim. Biophys. Acta Mol. Basis Dis. 2018;1864:2119&#x2013;2130.</Citation><ArticleIdList><ArticleId IdType="pubmed">29551730</ArticleId></ArticleIdList></Reference><Reference><Citation>Furukawa Y., O'Halloran T.V. Amyotrophic lateral sclerosis mutations have the greatest destabilizing effect on the apo- and reduced form of SOD1, leading to unfolding and oxidative aggregation. J.&#xa0;Biol. Chem. 2005;280:17266&#x2013;17274.</Citation><ArticleIdList><ArticleId IdType="pubmed">15691826</ArticleId></ArticleIdList></Reference><Reference><Citation>Eleutherio E.C.A., Magalhaes R.S.S., Brasil A.D., Neto J.R.M., Paranhos L.D. SOD1, more than just an antioxidant. Arch. Biochem. Biophys. 2021;697:108701.</Citation><ArticleIdList><ArticleId IdType="pubmed">33259795</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiwari A., Hayward L.J. Mutant SOD1 instability: implications for toxicity in amyotrophic lateral sclerosis. Neurodegener. Dis. 2005;2:115&#x2013;127.</Citation><ArticleIdList><ArticleId IdType="pubmed">16909016</ArticleId></ArticleIdList></Reference><Reference><Citation>Banks C.J., Andersen J.L. Mechanisms of SOD1 regulation by post-translational modifications. Redox Biol. 2019;26:101270.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6658992</ArticleId><ArticleId IdType="pubmed">31344643</ArticleId></ArticleIdList></Reference><Reference><Citation>Banci L., Bertini I., Boca M., Calderone V., Cantini F., Girotto S., et al. Structural and dynamic aspects related to oligomerization of apo SOD1 and its mutants. Proc. Natl. Acad. Sci. U. S. A. 2009;106:6980&#x2013;6985.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2678485</ArticleId><ArticleId IdType="pubmed">19369197</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells N.G.M., Tillinghast G.A., O'Neil A.L., Smith C.A. Free energy calculations of ALS-causing SOD1 mutants reveal common perturbations to stability and dynamics along the maturation pathway. Protein Sci. 2021;30:1804&#x2013;1817.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8376412</ArticleId><ArticleId IdType="pubmed">34076319</ArticleId></ArticleIdList></Reference><Reference><Citation>Crisp M.J., Mawuenyega K.G., Patterson B.W., Reddy N.C., Chott R., Self W.K., et al. In&#xa0;vivo kinetic approach reveals slow SOD1 turnover in the CNS. J.&#xa0;Clin. Invest. 2015;125:2772&#x2013;2780.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4563686</ArticleId><ArticleId IdType="pubmed">26075819</ArticleId></ArticleIdList></Reference><Reference><Citation>Bystrom R., Andersen P.M., Grobner G., Oliveberg M. SOD1 mutations targeting surface hydrogen bonds promote amyotrophic lateral sclerosis without reducing apo-state stability. J.&#xa0;Biol. Chem. 2010;285:19544&#x2013;19552.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2885233</ArticleId><ArticleId IdType="pubmed">20189984</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y., Rhodes N.R., Abdolvahabi A., Kohn T., Cook N.P., Marti A.A., et al. Deamidation of asparagine to aspartate destabilizes Cu, Zn superoxide dismutase, accelerates fibrillization, and mirrors ALS-linked mutations. J.&#xa0;Am. Chem. Soc. 2013;135:15897&#x2013;15908.</Citation><ArticleIdList><ArticleId IdType="pubmed">24066782</ArticleId></ArticleIdList></Reference><Reference><Citation>Trist B.G., Genoud S., Roudeau S., Rookyard A., Abdeen A., Cottam V., et al. Altered SOD1 maturation and post-translational modification in amyotrophic lateral sclerosis spinal cord. Brain. 2022;145:3108&#x2013;3130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9473357</ArticleId><ArticleId IdType="pubmed">35512359</ArticleId></ArticleIdList></Reference><Reference><Citation>Strange R.W., Antonyuk S.V., Hough M.A., Doucette P.A., Valentine J.S., Hasnain S.S. Variable metallation of human superoxide dismutase: atomic resolution crystal structures of Cu-Zn, Zn-Zn and as-isolated wild-type enzymes. J.&#xa0;Mol. Biol. 2006;356:1152&#x2013;1162.</Citation><ArticleIdList><ArticleId IdType="pubmed">16406071</ArticleId></ArticleIdList></Reference><Reference><Citation>Lelie H.L., Liba A., Bourassa M.W., Chattopadhyay M., Chan P.K., Gralla E.B., et al. Copper and zinc metallation status of copper-zinc superoxide dismutase from amyotrophic lateral sclerosis transgenic mice. J.&#xa0;Biol. Chem. 2011;286:2795&#x2013;2806.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3024775</ArticleId><ArticleId IdType="pubmed">21068388</ArticleId></ArticleIdList></Reference><Reference><Citation>Tajiri M., Aoki H., Shintani A., Sue K., Akashi S., Furukawa Y. Metal distribution in Cu/Zn-superoxide dismutase revealed by native mass spectrometry. Free Radic. Biol. Med. 2022;183:60&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pubmed">35314356</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C.Y., Steffen J., Eide D.J. Cytosolic superoxide dismutase (SOD1) is critical for tolerating the oxidative stress of zinc deficiency in yeast. PLoS One. 2009;4:e7061.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2737632</ArticleId><ArticleId IdType="pubmed">19756144</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright G.S.A., Antonyuk S.V., Hasnain S.S. The biophysics of superoxide dismutase-1 and amyotrophic lateral sclerosis. Q.&#xa0;Rev. Biophys. 2019;52:e12.</Citation><ArticleIdList><ArticleId IdType="pubmed">31760962</ArticleId></ArticleIdList></Reference><Reference><Citation>Potter S.Z., Zhu H.N., Shaw B.F., Rodriguez J.A., Doucette P.A., Sohn S.H., et al. Binding of a single zinc ion to one subunit of copper-zinc superoxide dismutase apoprotein substantially influences the structure and stability of the entire homodimeric protein. J.&#xa0;Am. Chem. Soc. 2007;129:4575&#x2013;4583.</Citation><ArticleIdList><ArticleId IdType="pubmed">17381088</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahawneh M.A., Ricart K.C., Roberts B.R., Bomben V.C., Basso M., Ye Y., et al. Cu,Zn-superoxide dismutase increases toxicity of mutant and zinc-deficient superoxide dismutase by enhancing protein stability. J.&#xa0;Biol. Chem. 2010;285:33885&#x2013;33897.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2962488</ArticleId><ArticleId IdType="pubmed">20663894</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y., Mowery R.A., Shaw B.F. Effect of metal loading and subcellular pH on net charge of superoxide dismutase-1. J.&#xa0;Mol. Biol. 2013;425:4388&#x2013;4404.</Citation><ArticleIdList><ArticleId IdType="pubmed">23871896</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y., Abdolvahabi A., Shaw B.F. Protein charge ladders reveal that the net charge of ALS-linked superoxide dismutase can be different in sign and magnitude from predicted values. Protein Sci. 2014;23:1417&#x2013;1433.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4287002</ArticleId><ArticleId IdType="pubmed">25052939</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujiwara N., Nakano M., Kato S., Yoshihara D., Ookawara T., Eguchi H., et al. Oxidative modification to cysteine sulfonic acid of Cys111 in human copper-zinc superoxide dismutase. J.&#xa0;Biol. Chem. 2007;282:35933&#x2013;35944.</Citation><ArticleIdList><ArticleId IdType="pubmed">17913710</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler K.E., Takinami Y., Rainczuk A., Baker E.S., Roberts B.R. Utilizing ion mobility-mass spectrometry to investigate the unfolding pathway of Cu/Zn superoxide dismutase. Front. Chem. 2021;9:614595.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7900566</ArticleId><ArticleId IdType="pubmed">33634076</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe S., Nagano S., Duce J., Kiaei M., Li Q.X., Tucker S.M., et al. Increased affinity for copper mediated by cysteine 111 in forms of mutant superoxide dismutase 1 linked to amyotrophic lateral sclerosis. Free Radic. Biol. Med. 2007;42:1534&#x2013;1542.</Citation><ArticleIdList><ArticleId IdType="pubmed">17448900</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H., Zhu H., Eggers D.K., Nersissian A.M., Faull K.F., Goto J.J., et al. Copper(2+) binding to the surface residue cysteine 111 of His46Arg human copper-zinc superoxide dismutase, a familial amyotrophic lateral sclerosis mutant. Biochemistry. 2000;39:8125&#x2013;8132.</Citation><ArticleIdList><ArticleId IdType="pubmed">10889018</ArticleId></ArticleIdList></Reference><Reference><Citation>Leinartaite L., Saraboji K., Nordlund A., Logan D.T., Oliveberg M. Folding catalysis by transient coordination of Zn2+ to the Cu ligands of the ALS-associated enzyme Cu/Zn superoxide dismutase 1. J.&#xa0;Am. Chem. Soc. 2010;132:13495&#x2013;13504.</Citation><ArticleIdList><ArticleId IdType="pubmed">20822138</ArticleId></ArticleIdList></Reference><Reference><Citation>Sekhar A., Rumfeldt J.A.O., Broom H.R., Doyle C.M., Bouvignies G., Meiering E.M., et al. Thermal fluctuations of immature SOD1 lead to separate folding and misfolding pathways. ELife. 2015;4:e07296.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4475725</ArticleId><ArticleId IdType="pubmed">26099300</ArticleId></ArticleIdList></Reference><Reference><Citation>Keerthana S.P., Kolandaivel P. Interaction between dimer interface residues of native and mutated SOD1 protein: a theoretical study. J.&#xa0;Biol. Inorg. Chem. 2015;20:509&#x2013;522.</Citation><ArticleIdList><ArticleId IdType="pubmed">25578810</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang A.Y., Koone J.C., Dashnaw C.M., Zahler C.T., Shaw B.F. Complete charge regulation by a redox enzyme upon single electron transfer. Angew. Chem. Int. Ed. Engl. 2020;59:10989&#x2013;10995.</Citation><ArticleIdList><ArticleId IdType="pubmed">32212239</ArticleId></ArticleIdList></Reference><Reference><Citation>Chattopadhyay M., Nwadibia E., Strong C.D., Gralla E.B., Valentine J.S., Whitelegge J.P. The disulfide bond, but not zinc or dimerization, controls initiation and seeded growth in amyotrophic lateral sclerosis-linked Cu,Zn superoxide dismutase (SOD1) fibrillation. J.&#xa0;Biol. Chem. 2015;290:30624&#x2013;30636.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4683282</ArticleId><ArticleId IdType="pubmed">26511321</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayers J.I., McMahon B., Gill S., Lelie H.L., Fromholt S., Brown H., et al. Relationship between mutant Cu/Zn superoxide dismutase 1 maturation and inclusion formation in cell models. J.&#xa0;Neurochem. 2017;140:140&#x2013;150.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5283795</ArticleId><ArticleId IdType="pubmed">27727458</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>